1620 Investment Advisors’s Best Buy BBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Buy
5,223
+1,539
+42% +$102K 0.25% 110
2026
Q1
$237K Buy
3,684
+177
+5% +$11.6K 0.16% 135
2025
Q4
$235K Sell
3,507
-482
-12% -$36.8K 0.16% 139
2025
Q3
$302K Buy
3,989
+131
+3% +$9.39K 0.2% 125
2025
Q2
$259K Sell
3,858
-2,456
-39% -$167K 0.18% 132
2025
Q1
$465K Buy
6,314
+12
+0.2% +$989 0.36% 86
2024
Q4
$541K Buy
6,302
+176
+3% +$16.1K 0.41% 76
2024
Q3
$633K Buy
6,126
+35
+0.6% +$3.15K 0.46% 60
2024
Q2
$513K Buy
6,091
+15
+0.2% +$1.19K 0.39% 70
2024
Q1
$498K Buy
6,076
+267
+5% +$20.3K 0.5% 65
2023
Q4
$455K Buy
+5,809
New +$409K 0.5% 70
2023
Q3
Sell
-8,868
Closed -$727K 142
2023
Q2
$727K Sell
8,868
-162
-2% -$12.1K 0.79% 37
2023
Q1
$707K Sell
9,030
-192
-2% -$15.8K 0.85% 37
2022
Q4
$740K Buy
9,222
+224
+2% +$16.5K 0.9% 37
2022
Q3
$570K Buy
+8,998
New +$666K 0.84% 38

Other funds holding BBY

1620 Investment Advisors's BBY Position: Q2 2026 in Review

1620 Investment Advisors increased its Best Buy (BBY) stake by 42% in Q2 2026, buying an estimated $102K and bringing the position to 5,223 shares worth $396K. The position accounts for 0.25% of the portfolio, ranked #110.

1620 Investment Advisors first reported a position in BBY in Q3 2022 and has held it in 15 quarters since. The position peaked at $740K in Q4 2022. 258 funds tracked by Wall St. Rank hold BBY as of Q2 2026.

  • 1620 Investment Advisors held 5,223 shares of Best Buy worth $396K as of Q2 2026.
  • 1620 Investment Advisors bought 1,539 Best Buy shares in Q2 2026, an estimated $102K.
  • Best Buy made up 0.25% of 1620 Investment Advisors's portfolio in Q2 2026, its #110 holding.
  • 1620 Investment Advisors first reported a position in Best Buy in Q3 2022 and has held it in 15 quarters since.
  • 1620 Investment Advisors's Best Buy position peaked at $740K in Q4 2022.
  • 258 funds tracked by Wall St. Rank held Best Buy as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.